Heterotrimeric Gα(i) proteins are regulated by lipopolysaccharide and are anti-inflammatory in endotoxemia and polymicrobial sepsis.
Previous studies have implicated a role of heterotrimeric Gα(i) proteins in lipopolysaccharide (LPS)-induced inflammatory responses. We hypothesized that Toll-like receptor (TLR) signaling regulates Gα(i) proteins, which are anti-inflammatory in endotoxemia and polymicrobial sepsis. RAW 264.7 cells were stimulated with LPS and the Gα(i)-GTP protein complex was immunoprecipitated with a Gα(i) protein activation assay. In subsequent in vivo studies, the Gα(i) protein inhibitor pertussis toxin (PTx) or G(i) protein agonist mastoparan (MP-7) were administrated prior to endotoxemia. LPS-induced pro-inflammatory cytokines and mortality were determined. To examine the role of Gα(i2) in sepsis, Gα(i2) (-/-) and wildtype (WT) mice were subjected to cecal ligation and puncture (CLP) and monitored every 24 h for 120 h. Other mice were sacrificed 24 h after CLP. Peritoneal fluid, blood, and tissue samples were collected. Plasma pro-inflammatory cytokine production, bacterial load in peritoneal fluid, blood and lung tissue, myeloperoxidase (MPO) activity in lung and liver and different immune cell populations in spleen were studied. We found that Gα(i) proteins are rapidly activated by LPS followed by rapid inactivation. These studies provide the first direct evidence that Gα(i) proteins are modulated by TLR signaling. In following studies, PTx augmented LPS-induced plasma TNFα, IL-6, whereas MP-7 suppressed LPS-induced TNFα and decreased LPS-induced mortality. In sepsis studies, the survival rate post-CLP was significantly decreased in the Gα(i2) (-/-) mice compared to WT mice. CLP-induced plasma TNFα, IL-6, bacterial load in peritoneal fluid, blood and lung tissue and lung and liver MPO activity were significantly increased in Gα(i2) (-/-) compared to WT mice. Gα(i2) (-/-) mice also exhibited increased Th1 and Th2 responses compared to WT mice. Taken together, Gα(i) proteins are activated by LPS and negatively regulate endotoxemia and sepsis. Understanding the role of Gα(i2) protein in regulation of the inflammatory response in sepsis may provide novel targets for treatment of sepsis.
Department of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA. fanhong@musc.edu
Hongkuan
H
Fan
Pengfei
P
Li
Basilia
B
Zingarelli
Keith
K
Borg
Perry V
PV
Halushka
Lutz
L
Birnbaumer
James A
JA
Cook
D000818:Animals; D058491:Bacterial Load; D002432:Cecum / Q000293:injuries / Q000601:surgery; D002460:Cell Line; D016207:Cytokines / Q000097:blood / Q000276:immunology; D019446:Endotoxemia / Q000276:immunology*; D051960:GTP-Binding Protein alpha Subunit, Gi2 / Q000235:genetics / Q000276:immunology; D019206:GTP-Binding Protein alpha Subunits, Gi-Go / Q000235:genetics / Q000276:immunology*; D017353:Gene Deletion; D036341:Intercellular Signaling Peptides and Proteins; D008070:Lipopolysaccharides / Q000276:immunology*; D051379:Mice; D018345:Mice, Knockout; D010455:Peptides / Q000276:immunology; D009195:Peroxidase / Q000276:immunology; D037342:Pertussis Toxin / Q000276:immunology; D018805:Sepsis / Q000276:immunology*; D013154:Spleen / Q000166:cytology; D006377:T-Lymphocytes, Helper-Inducer / Q000166:cytology; D014862:Wasp Venoms / Q000276:immunology
D016207:Cytokines; D036341:Intercellular Signaling Peptides and Proteins; D008070:Lipopolysaccharides; D010455:Peptides; D014862:Wasp Venoms; C037500:mastoparan; D009195:Peroxidase; D037342:Pertussis Toxin; D051960:GTP-Binding Protein alpha Subunit, Gi2; D019206:GTP-Binding Protein alpha Subunits, Gi-Go
J Biol Chem. 2010 May 14;285(20):15268-15277
20231290
Am J Physiol Cell Physiol. 2005 Aug;289(2):C293-301
15788486
Nat Immunol. 2001 Apr;2(4):338-45
11276205
J Immunol. 2005 Apr 1;174(7):4252-61
15778388
Eur J Immunol. 2008 Jan;38(1):192-203
18081034
Cell. 2006 Feb 24;124(4):783-801
16497588
Nat Rev Immunol. 2006 Nov;6(11):813-22
17039247
FEBS Lett. 2005 Jan 31;579(3):699-704
15670831
J Immunol. 2006 Dec 1;177(11):7943-9
17114466
Crit Care Med. 2001 Jul;29(7):1303-10
11445675
J Immunol. 2004 Sep 1;173(5):3035-43
15322163
Eur Cytokine Netw. 2001 Oct-Dec;12(4):631-8
11781190
Immunology. 2010 Jul;130(3):344-51
20465566
Immunity. 2006 Jun;24(6):677-688
16782025
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2274-9
16461893
Nat Genet. 1995 Jun;10(2):143-50
7663509
Annu Rev Physiol. 2007;69:535-60
17002593
Biochim Biophys Acta. 2006 Oct;1763(10):1051-8
16962188
J Exp Med. 2006 Jan 23;203(1):131-40
16380513
Shock. 2004 Jul;22(1):57-62
15201703
J Immunol. 1993 Feb 1;150(3):1011-8
8423328
Shock. 2002 Jun;17(6):463-7
12069181
JAMA. 1996 Aug 21;276(7):565-6
8709407
Mol Med Today. 1999 Mar;5(3):123-32
10203736
Annu Rev Immunol. 2007;25:787-820
17291188
J Clin Invest. 1998 Dec 1;102(11):2019-27
9835628
J Biol Chem. 2002 Apr 26;277(17):14884-93
11842088
Nat Rev Immunol. 2004 Jul;4(7):499-511
15229469
J Immunol. 2006 Jan 15;176(2):1209-17
16394011
Crit Care Med. 2003 Sep;31(9):2316-23
14501962
J Immunol. 2000 Apr 1;164(7):3471-5
10725698
J Biol Chem. 1997 Aug 1;272(31):19125-32
9235901
J Immunol. 2005 Sep 1;175(5):3282-6
16116220